NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients

Abstract

To assess whether NLR pyrin domain-containing protein 3 (NLRP3) inflammasome, a multiprotein complex that mediates the activation of caspase-1 (CASP-1) and pro-inflammatory cytokines IL-18 and IL-1β, could be involved in the chronic inflammatory state observed in chronic kidney disease patients undergoing hemodialysis treatment (CKD-HD), we employed several biomolecular techniques including RT-PCR, western blot, FACS analysis, confocal microscopy and microarray. Interestingly, peripheral blood mononuclear cells from 15 CKD-HD patients showed higher mRNA levels of NLRP3, CASP-1, ASC, IL-1β, IL-18 and P2X7receptor compared to 15 healthy subjects. Western blotting analysis confirmed the above results. In particular, active forms of CASP-1, IL1-β and IL-18 resulted significantly up-regulated in CKD-HD versus controls. Additionally, elevated mitochondrial ROS level, colocalization of NLRP3/ASC/mitochondria in peripheral blood mononuclear cells from CKD-HD patients and down-regulation of CASP-1, IL1-β and IL-18 protein levels in immune-cells of CKD-HD patients stimulated with LPS/ATP in presence of mitoTEMPO, inhibitor of mitochondrial ROS production, suggested a possible role of this organelle in the aforementioned CKD-associated inflammasome activation. Then, microarray analysis confirmed, in an independent microarray study cohort, that NLRP3 and CASP-1, along with other inflammasome-related genes, were up-regulated in 17 CKD-HD patients and they were able to clearly discriminate these patients from 5 healthy subjects. All together these data showed, for the first time, that NLRP3 inflammasome was activated in uremic patients undergoing dialysis treatment and they suggested that this unphysiological condition could be possibly induced by mitochondrial dysfunction.

Paraoxonase 1 and atherosclerosis‐related diseases

“…This was further described in the paper by Granata and colleagues. Direct inflammasome activation in uremic patients led to mitochondrial dysfunction and oxidative stress burden . Chen and associates confirmed that low albumin concentration was related to cardiovascular and overall mortality in hemodialysis patients .…”

Bioactive food and exercise in chronic kidney disease: Targeting the mitochondria

“…In CKD, mitochondrial dysfunction is a major contributor to oxidative stress that associates with many uraemic complications, including inflammation and vascular damage that promote cardiovascular disease and premature ageing . Furthermore, there is a reduction in mtDNA copy number, a valuable biomarker for mitochondrial rupture in renal diseases, loss of mitochondrial membrane potential and reduced ATP production in CKD, and inflammation and oxidative stress, in turn, appear to promote mitochondrial dysfunction . During oxidant insults, several mitochondrial functions are affected including increased permeability of mitochondrial transition pores that leads to membrane potential depolarization, inhibition of electron transport, increased oxidant production and low respiratory activity, reduced intracellular ATP levels, alterations in mitochondrial membrane potential (Δψ m ) and triggering the release of cytochrome C (cyt C) to the cytoplasm that can result in activation of caspases, leading to cell death …”

A Protective Role of Glibenclamide in Inflammation-Associated Injury

“…Expression of the NLRP3 inflammasome is enhanced in chronic kidney diseases [42]. Inflammatory markers, including TNF- α and NLRP3, were highly expressed in the kidneys from adenine diet-treated rats.…”